DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Rosenstock J, Sankoh S, List J.
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes*.
Diabetes ObesMetab 2008;
10: 376-386
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.